Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

News Coverage

The Early Introduction Paradox: Why Infant ER Visits Are Rising Despite Successful Guidelines

Study Finds Advanced Parental Age Linked to Lower Allergy Risks

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for Food Allergy Treatments

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy Remission

EpiPen Price Hikes Lead Senator to Sponsor Legislation, But Will it...

Symjepi, the Auto-Injector Alternative, to Launch Q1 2019

Did the Cost of a Left-Behind EpiPen Contribute to a Murder...

Non-Profit Institute to Review Benefits of Commercial, Private Practice Immunotherapies for...

Teva Launches EpiPen Generic in US Priced at $300

Study: Use Multiple Strategies to Safely Dine Out with Food Allergies

Parents Wonder Whether Epinephrine Would Have Saved Megan Lee's Life

Study: Nearly Half of Adults with Food Allergies Reported An Onset...

Study: Does Prior Administration of Epinephrine Adversely Impact Pediatric Anaphylaxis Patients?

New Treatment to Protect People with Peanut Allergies Ready for FDA...

Your School On Our Map

Put Your School on the Map